Exosens delivers strong performance in H1 2026, driven by sustained momentum in night vision and accelerating demand in defense imaging; 2026 outlook: Now expecting to be towards the upper end of the guidance

EXOSENS DELIVERS STRONG PERFORMANCE IN H1 2026, DRIVEN BY SUSTAINED MOMENTUM IN NIGHT VISION AND ACCELERATING DEMAND IN DEFENSE IMAGING

2026 OUTLOOK: NOW EXPECTING TO BE TOWARDS THE UPPER END OF THE GUIDANCE

HIGHLIGHTS

• Sustai ed eve ue g owth of +15.3% to €253.1 millio i H1 2026, i cludi g st o g LFL g owth of +11.4%, d ive by accele ati g dema d fo adva ced defe se imagi g a d ight visio solutio s
  • Amplificatio eve ue up +11.6%, with st o g LFL¹ g owth (+10.0%), suppo ted by g owi g dema d fo high-pe fo ma ce image i te sifie tubes i missio -c itical ight visio applicatio s
  • D&I eve ue up +24.3%, with accele ati g LFL g owth (+14.6%), co fi mi g i c easi g adoptio of Exose s’ adva ced imagi g tech ologies ac oss Defe se & Su veilla ce ma kets, pa ticula ly i d o e a d cou te -d o e applicatio s
• Sig ifica t imp oveme t p ofitability, with adjusted EBITDA of €83.6 millio i H1 2026 (+18.3%), ep ese ti g a ew eco d-high ma gi of 33.0% (+84Bps vs. H1 2025), d ive by st o g eve ue g owth a d co ti ued ope atio al excelle ce
• Net p ofit f om co ti ued ope atio s, excludi g the o e-off t adema k impai me t cha ge², of €35.9 millio i H1 2026 (+21.4%); et p ofit of €15.3 millio
• Sou d capital st uctu e suppo ti g ou g owth st ategy, with leve age atio of 1.2x as at 30 Ju e 2026 (vs. 1.3x as at 31 Decembe 2025); st e gthe ed liquidity p ofile with exte ded RCF of €200 millio a d ew €140 millio EIB fi a ci g facility
• Night visio capacity expa sio p og essi g as pla ed ac oss Eu ope a d the U.S., with fi st be efits f om the Eu opea expa sio expected f om H2 2026; additio al p oductio capacity u de active evaluatio as dema d co ti ues to st e gthe
• Scali g p oductio capacity fo adva ced imagi g solutio s to suppo t accele ati g dema d ac oss d o e, cou te -d o e a d lo g- a ge su veilla ce applicatio s
• Co ti ued discipli ed executio of ou ta geted, value-c eati g M&A st ategy with the acquisitio of Embe io , a compa y specializi g i qua tum dot-based i f a ed se so s; p op ieta y tech ology compleme ti g Exose s’ po tfolio a d suppo ti g g owth oppo tu ities i Defe se & Su veilla ce a d I dust ial Co t ol ma kets

OUTLOOK

• Fully o t ack to delive o ou 2026 guida ce: ow expecti g eve ue a d adjusted EBITDA to be towa ds the uppe e d of thei espective a ges
  • Reve ue i the a ge of €520 millio to €540 millio
  • Adjusted EBITDA i the a ge of €168 millio to €178 millio
  • Capital expe ditu e at a ou d 9% of 2026 eve ue (ex. capitalized R&D), d ive by p oductio capacity expa sio i Eu ope a d the U ited States

P ess elease, Mé ig ac (F a ce), 28 July 2026 – Exose s (EXENS; FR001400Q9V2), a high-tech compa y focused o p ovidi g missio – a d pe fo ma ce-c itical amplificatio , detectio a d imagi g tech ologies, today eleases its esults fo six-mo th pe iod e ded 30 Ju e 2026³.

“Ou fi st-half pe fo ma ce eflects both sustai ed comme cial mome tum a d discipli ed executio , with ove +11% like-fo -like eve ue g owth a d a eco d 33% adjusted EBITDA ma gi . I Amplificatio , dema d fo adva ced ight visio solutio s emai s st o g, while ou capacity expa sio pla is p og essi g as expected. We also achieved a key milesto e i ou U.S. st ategy with the awa d of the U.S. A my BiNOD co t act. I Detectio & Imagi g, we co ti ue to be efit f om the g owi g adoptio of ou adva ced imagi g tech ologies ac oss d o e, cou te -d o e a d lo g- a ge su veilla ce applicatio s, co t ibuti g to +15% like-fo -like g owth i the fi st half. We a e also scali g ou imagi g p oductio capacity to suppo t accele ati g custome dema d. Beyo d Defe se & Su veilla ce, uclea co ti ues to delive st o g mome tum, with i c easi g i vestme t i ext-ge e atio SMR tech ologies, pa ticula ly i the U.S. Looki g ahead, we emai fully o t ack to delive o ou 2026 guida ce a d ow expect both eve ue a d adjusted EBITDA to be towa ds the uppe e d of thei espective a ges”, said Jé ôme Ce isie , CEO of Exose s.

Key fi a cial i dicato s⁴

St o g H1 2026 eve ue pe fo ma ce, d ive by accele ati g dema d ac oss global defe se a d su veilla ce ma kets

The G oup’s co solidated eve ue eached €253.1 millio i H1 2026, ep ese ti g st o g g owth of +15.3% (+€33.6 millio ) compa ed with H1 2025. This pe fo ma ce eflects the co t ibutio f om 2025 acquisitio s a d sustai ed like-fo -like g owth of +11.4% yea -o -yea , mai ly d ive by accele ati g dema d fo adva ced ight visio a d imagi g solutio s suppo ti g missio -c itical defe se a d su veilla ce applicatio s.

AMPLIFICATION

Amplificatio eve ue amou ted to €176.3 millio (c.70% of G oup sales) i H1 2026, up +11.6% (+€18.4 millio ) compa ed with H1 2025, d ive by highe sales volumes, imp oved yields a d a favo able p oduct mix. Like-fo -like g owth was also obust, eachi g +10.0% i H1 2026.

Global defe se ma kets co ti ued to be efit f om sustai ed st uctu al dema d i H1 2026, d ive by i c easi g defe se spe di g a d the co ti ued mode izatio of a med fo ces, esulti g i accele ated p ocu eme t of adva ced ight visio systems. As the wo ld’s leadi g supplie of high-pe fo ma ce, ITAR-f ee image i te sifie tubes, Exose s fu the st e gthe ed its positio as a st ategic pa t e to NATO membe s a d Tie 1 allies, suppo ted by its tech ological leade ship a d i dust ial capabilities.

Comme cial mome tum emai ed pa ticula ly st o g i Eu ope, suppo ted by the co ti ued executio of majo ight visio p ocu eme t p og ams, i cludi g the OCCAR f amewo k fo the Ge ma a d Belgia a med fo ces, as well as sustai ed dema d ac oss Easte a d No the Eu ope. The adoptio of 5G co ti ues to expa d, d ive by g owi g dema d f om special fo ces ac oss NATO cou t ies.

Agai st the backd op of accele ati g global dema d a d with ight visio equipme t pe et atio emai i g well below e d use s’ ta get levels ove the mid-te m, Exose s a ou ced i 2025 a i vestme t pla to expa d its p oductio capacity i Eu ope a d the U.S., ta geti g a 40% i c ease by 2027. The pla is p og essi g o schedule, with the fi st be efits f om the Eu opea capacity expa sio expected f om H2 2026.

I the U.S., the ollout of the ew ma ufactu i g facility is u de way, establishi g scalable i -cou t y p oductio capacity to suppo t futu e g owth i the wo ld’s la gest si gle ight visio ma ket. U de sco i g the effective ess of its i dust ial st ategy, Exose s eached a key milesto e with the awa d of a majo IDIQ U.S. A my co t act fo the developme t, p oductio a d testi g of Bi ocula Night Obse vatio Device (BiNOD). This co t act ma ks a ew phase i the G oup’s U.S. expa sio , positio i g Exose s as a pa t e to the U.S. A my while suppo ti g sig ifica t lo g-te m g owth oppo tu ities i the U.S. defe se ma ket.

With dema d co ti ui g to st e gthe , Exose s is actively evaluati g fu the capacity additio s to suppo t g owi g dema d i the ight visio ma ket.

DETECTION & IMAGING

Detectio & Imagi g eve ue eached €77.4 millio (c.31% of G oup sales) i H1 2026, up +24.3% (+€15.1 millio ) compa ed with H1 2025. This pe fo ma ce eflects the co t ibutio f om 2025 acquisitio s (Noxa t, Phasics), as well as st o g like-fo -like g owth of +14.6%, suppo ted by sustai ed dema d ac oss the defe se a d su veilla ce ma kets, pa ticula ly i d o e a d cou te -d o e applicatio , a d co ti ued st e gth i uclea i st ume tatio .

Defe se & Su veilla ce

Imagi g tech ologies a e becomi g ce t al to mode defe se ope atio s, d ive by two co ve gi g t e ds: (i) the g owi g adoptio of adva ced opt o ic tech ologies ac oss platfo m-based applicatio s a d (ii) the apid p olife atio of d o es a d cou te -d o e systems as a co e pilla of mode wa fa e. Agai st this favo able backd op, Exose s is well positio ed to capitalize o accele ati g ma ket g owth th ough its comp ehe sive po tfolio of adva ced imagi g solutio s. Spa i g multi-spect al a d multi-domai capabilities, these tech ologies e able situatio al awa e ess, th eat detectio , ide tificatio a d t acki g, ta geti g, a d lo g- a ge obse vatio , e ha ci g missio effective ess fo defe se a d su veilla ce applicatio s.

Comme cial mome tum co ti ued to accele ate ac oss the fast-g owi g d o e a d cou te -d o e ma ket, d ive by i c easi g adoptio of Exose s’ imagi g tech ologies by leadi g OEMs a d auto omous systems develope s. U de sco i g this st o g mome tum, the G oup secu ed a eco d o de fo i te cepto d o e-based imagi g solutio s f om a majo Eu opea ai defe se systems develope , demo st ati g its tech ological leade ship i ext-ge e atio auto omous defe se systems. Exose s leve ages its deep u de sta di g of the UxV ma ket equi eme ts a d its ability to suppo t custome s th oughout the desig -i phase, e abli g faste time-to-ma ket. This is fu the ei fo ced by agile supply chai a d scalable p oductio capacity, e abli g apid espo se to accele ati g dema d.

Su veilla ce ma kets co ti ued to be efit f om i c easi g i vestme ts i homela d secu ity a d cou te -d o e capabilities amid isi g sove eig ty co ce s a d the g owi g th eat of la d a d ai bo e i cu sio s. Dema d emai ed st o g, pa ticula ly fo adva ced imagi g solutio s e abli g lo g- a ge su veilla ce a d cou te -d o e ope atio s, with Exose s’ tech ologies i c easi gly adopted by leadi g OEMs a d system i teg ato s.

To suppo t this accele ati g dema d, the G oup is doubli g its p oductio capacity fo cooled i f a ed came as i 2026, highlighti g its ability to a ticipate apidly evolvi g ma ket equi eme ts a d scale p oductio capacity to meet g owi g dema d.

Comme cial Ma kets

I Nuclea , comme cial mome tum emai ed st o g, with g owi g dema d fo adva ced detecto s a d i st ume ts. The uclea ma ket co ti ues to be efit f om isi g eeds fo ca bo -f ee e e gy, due to the apid expa sio a d u p ecede ted powe equi eme ts of AI-e abled data ce te s, ei fo ci g lo g-te m i vestme t i SMR-specific tech ologies. Rece t developme ts i the U.S., i cludi g key milesto es achieved u de the Depa tme t of E e gy’s Reacto Pilot P og am, co fi m the accele ati g deployme t of ext-ge e atio uclea tech ologies. These achieveme ts a e expected to t a slate i to p e-se ies p oductio o de s i the ea te m a d suppo t lo g-te m dema d fo Exose s’ adva ced uclea i st ume tatio solutio s, pa ticula ly ac oss SMR applicatio s.

I I dust ial Co t ol, ma ket co ditio s imp oved, showi g ea ly sig s of ecove y. The accele ati g deployme t of AI i f ast uctu e is expected to d ive e ewed i vestme t i semico ducto ma ufactu i g a d adva ced i dust ial automatio , suppo ti g dema d fo high-pe fo ma ce imagi g tech ologies used i semico ducto i spectio , machi e visio , a d eal-time p ocess mo ito i g. Exose s is well positio ed to be efit f om these t e ds th ough its cutti g-edge po tfolio of i f a ed, UV a d wavef o t se si g tech ologies.

I Life Scie ces, global u ce tai ty co ti ued to weigh o scie tific esea ch a d dema d fo mic oscopy compo e ts, while i ve to y d awdow s i mass spect omet y seem to be ea i g completio afte havi g tempo a ily softe ed dema d fo adva ced detecto s. Despite these tempo a y headwi ds, ma ket fu dame tals emai favo able, d ive by the t a sitio towa d highe -pe fo ma ce mass spect omet y systems a d i c eased R&D i vestme ts i ext-ge e atio life scie ces applicatio s, suppo ti g lo g-te m dema d fo Exose s’ adva ced detectio solutio s.

M&A

O 24 Ap il 2026, Exose s completed the acquisitio of Embe io , a Fi la d- a d UK-based compa y specializi g i the desig a d ma ufactu i g of i ovative i f a ed se so s leve agi g pate ted qua tum dot imagi g tech ology. This acquisitio st e gthe s Exose s’ positio as a leadi g p ovide of adva ced imagi g solutio s, with the additio of eme gi g qua tum dot-based sho t-wave i f a ed se so s, suppo ti g ew g owth oppo tu ities i the high- esolutio defe se a d su veilla ce ma kets, pa ticula ly fo po table a d d o e-based imagi g systems, as well as i i dust ial co t ol applicatio s such as semico ducto i spectio .

Adjusted g oss ma gi up +16.5% i H1 2026

The G oup’s adjusted g oss ma gi eached €129.9 millio i H1 2026, up +16.5% (+€18.4 millio ) compa ed with €111.5 millio i H1 2025. As a pe ce tage of sales, adjusted g oss ma gi i c eased by +53 basis poi ts to 51.3% i H1 2026 (ve sus 50.8% i H1 2025).

The Amplificatio segme t’s adjusted g oss ma gi amou ted to €92.6 millio i H1 2026, up +14.0% (+€11.4 millio ) compa ed with H1 2025. Ma gi ate i c eased by +109 basis poi ts to 52.5% i H1 2026 (ve sus 51.5% i H1 2025), d ive by i c eased sales volumes, imp oved yields a d a favo able p oduct mix.

The Detectio & Imagi g segme t’s adjusted g oss ma gi amou ted to €37.2 millio i H1 2026, up +22.8% (+€6.9 millio ) compa ed with H1 2025. Ma gi ate dec eased by (60) basis poi ts to 48.1% i H1 2026 (ve sus 48.7% i H1 2025). This ma gi decli e eflects a less favo able p oduct mix, d ive by lowe sales of high-ma gi life scie ces detecto s.

Reco d-high p ofitability d ive by st o g ope atio al executio i H1 2026

Exose s delive ed fu the p ofitability imp oveme t i H1 2026, achievi g eco d-high ma gi s a d st e gthe i g its best-i -class p ofitability p ofile. This pe fo ma ce was d ive by highe sales volumes, co ti ued yield imp oveme t a d a favo able p oduct mix.

Adjusted EBITDA eached €83.6 millio i H1 2026, up +18.3% (+€12.9 millio ) compa ed with €70.6 millio i H1 2025. As a esult, adjusted EBITDA ma gi i c eased by +84 basis poi ts to 33.0% i H1 2026 (ve sus 32.2% i H1 2025), eachi g a eco d-high level fo the G oup, d ive by sustai ed eve ue g owth a d co ti ued ope atio al excelle ce.

Adjusted EBIT amou ted to €71.7 millio i H1 2026, up +19.2% (+€11.5 millio ) compa ed with €60.2 millio i H1 2025. As a esult, adjusted EBIT ma gi ose by +92 basis poi ts to 28.4% i H1 2026 (ve sus 27.4% i H1 2025).

Excludi g a €(28.2) millio o -cash t adema k impai me t cha ge ecog ized i co ectio with the G oup’s eb a di g u de the si gle Exose s b a d, ope ati g i come amou ted to €59.4 millio i H1 2026, up +21.2% (+€10.4 millio ) compa ed with €49.0 millio i H1 2025. As a esult, the G oup’s ope ati g ma gi i c eased by +114 basis poi ts to 23.5% i H1 2026 (ve sus 22.3% i H1 2025).

Net p ofit f om co ti ued ope atio s ex-impai me t of €35.9 millio i H1 2026

Excludi g €(20.6) millio et o -cash impact of t adema k impai me t⁵, the G oup’s posted a et p ofit f om co ti ued ope atio s⁶ of €35.9 millio i H1 2026, up by +21.4% (+€6.3 millio ) compa ed with €29.6 millio i H1 2025. O a epo ted basis, et p ofit was €15.3 millio i H1 2026 compa ed with €27.9 millio i H1 2025.

Robust f ee cash flow ge e atio despite i c eased g owth capex i H1 2026

Exose s ge e ated f ee cash flow of €31.4 millio i H1 2026 compa ed with €30.0 millio i H1 2025. The st o g i c ease i the G oup’s adjusted EBITDA was pa tly offset by highe g owth capital expe ditu e elated to the o goi g impleme tatio of its p oductio capacity expa sio pla . The G oup also mai tai ed discipli ed wo ki g capital ma ageme t despite st o g eve ue g owth, leadi g to a imp oveme t i wo ki g capital days of sales.

Sustai ed R&D i vestme t i H1 2026, suppo ti g tech ology leade ship

G oss R&D expe ses eached €20.1 millio (7.9% of sales) i H1 2026, up +18.0% (+€3.1 millio ) compa ed with H1 2025. The G oup co ti ued its sustai ed i vestme t i R&D to foste i ovatio a d st e gthe its tech ological leade ship, focusi g o adva ced ight visio , detectio a d imagi g solutio s add essi g evolvi g custome eeds ac oss Defe se & Su veilla ce, I dust ial Co t ol, Life Scie ces a d Nuclea ma kets. These i ovatio s a e expected to suppo t futu e g owth, while ei fo ci g Exose s’ leadi g tech ology positio .

Accele ated i vestme t i p oductio capacity i H1 2026

Capital expe ditu e (excludi g capitalized R&D expe ses) amou ted to €23.3 millio (9.2% of sales) i H1 2026, up +59.6% (+€8.7 millio ) compa ed with H1 2025. G owth capex was €18.7 millio (7.4% of sales) i H1 2026, ep ese ti g a i c ease of +98.6% compa ed with H1 2025, d ive by i vestme t i pla t i f ast uctu e wo ks a d additio al equipme t i the G oup’s light amplificatio facto ies. Mai te a ce capex was €4.7 millio (1.8% of sales) i H1 2026, focused o p oductivity-e ha ci g p ojects, d ivi g futu e ma gi expa sio .

Sou d bala ce sheet, suppo ti g ou g owth st ategy

Net fi a cial debt stood at €199.8 millio as at 30 Ju e 2026 compa ed with €197.7 millio as at 31 Decembe 2025. Acco di gly, the leve age atio eached 1.2x as at 30 Ju e 2026 compa ed with 1.3x as at 31 Decembe 2025, p ovidi g the G oup with ample fi a cial flexibility to suppo t its lo g-te m g owth st ategy.

The G oup also mai tai ed a st o g liquidity positio , with €68.8 millio i cash a d cash equivale ts as at 30 Ju e 2026. Du i g the pe iod, Exose s ei fo ced its fu di g esou ces th ough the exte sio of its Revolvi g C edit Facility (RCF) f om €100 millio to €200 millio , with imp oved fi a cial te ms, a d by secu i g a ew €140 millio fi a ci g facility with the Eu opea I vestme t Ba k (EIB).

2026 outlook: Now expecti g to be towa ds the uppe e d of guida ce

Buildi g o sustai ed comme cial mome tum, pa ticula ly i the Defe se a d Su veilla ce ma kets, a d st o g ope atio al executio , Exose s emai s fully o t ack to delive o its 2026 guida ce a d ow expects eve ue a d adjusted EBITDA to be towa ds the uppe e d of thei espective a ges:

• Reve ue i the a ge of €520 millio to €540 millio ;
• Adjusted EBITDA i the a ge of €168 millio to €178 millio .

I additio , the G oup i te ds to co ti ue impleme ti g its i vestme t pla aimed at expa di g p oductio capacity by 40% by 2027, both i Eu ope a d the U ited States, to meet st o g dema d, while co ti ui g its effo ts to imp ove p oductivity. I this co text, the G oup expects capital expe ditu e to ep ese t a ou d 9% of 2026 eve ue (excludi g capitalized R&D expe ses, expected at a ou d 3% of eve ue).

Webcast

Jé ôme Ce isie , CEO a d Quy h-Boi Demey, CFO will hold a co fe e ce call a d webcast to discuss Exose s’ Fi st-Half 2026 esults o Tuesday, 28 July 2026 at 9:00 a.m. CEST. This p ese tatio will be followed by a Q&A sessio a d ca be accessed via the followi g li k:

https://exose s.e gagest eam.eu o ext.com/2026-half-yea – esults.

The p ess elease a d the p ese tatio will be available i the I vesto Relatio s sectio o Exose s’ website at www.exose s.com/i vesto s.

Fi a cial Cale da

• 27/10/2026: 9M 2026 eve ue & adjusted g oss ma gi (befo e ma ket ope i g).

About Exose s

Exose s is a high‐tech compa y, with mo e tha 85 yea s of expe ie ce i the i ovatio , developme t, ma ufactu i g a d sale of high‐e d elect o‐optical tech ologies i the fields of amplificatio , detectio , a d imagi g. Today, it offe s its custome s detectio compo e ts a d solutio s such as adva ced came as, eut o a d gamma detecto s, i st ume t detecto s a d image i te sifie tubes. This allows Exose s to espo d to complex issues i ext emely dema di g e vi o me ts by offe i g tailo -made solutio s to its custome s. Tha ks to its sustai ed i vestme ts, Exose s is i te atio ally ecog ized as a majo i ovato i optoelect o ics, with p oductio a d R&D ca ied out o 13 sites, i Eu ope a d No th Ame ica, a d with ove 2,000 employees. Exose s is listed o compa tme t A of the egulated ma ket of Eu o ext Pa is (Ticke : EXENS – ISIN: FR001400Q9V2). Exose s is a membe of Eu o ext Tech Leade s segme t a d is also i cluded i seve al i dices, i cludi g SBF 120, CAC All-T adable, CAC Mid 60, FTSE Total Cap a d MSCI F a ce Small Cap. Fo mo e i fo matio : www.exose s.com.

I vesto Relatio s

Lau e t Sfaxi, l.sfaxi@exose s.com

Media Relatio s

B u swick G oup, exose s@b u swickg oup.com

APPENDICES

Qua te ly figu es fo H1 2026

Qua te ly figu es fo H1 2025

Reco ciliatio of adjusted EBITDA a d adjusted EBIT

Reco ciliatio of f ee cash flow

Co solidated stateme t of i come

Co solidated stateme t of cash flows

Co solidated bala ce sheet – Assets

Co solidated bala ce sheet – Equity a d liabilities

Defi itio s

Like-fo -like g owth is defi ed as the eve ue g owth achieved by the G oup, excludi g cu e cy effects a d cha ges i the scope of co solidatio . It co espo ds to the eve ue ge e ated i pe iod “ ” by all compa ies i cluded i the G oup’s scope of co solidatio at the e d of pe iod “ -1” (excludi g a y co t ibutio f om compa ies acqui ed si ce the e d of pe iod “ -1”), compa ed with the eve ue ge e ated i pe iod “ -1” by the same compa ies. Acco di gly, like-fo -like g owth fo the six-mo th pe iod e ded 30 Ju e 2026 excludes the co t ibutio of Noxa t, NVLS a d Phasics, which we e acqui ed by the G oup i Ma ch 2025, July 2025 a d Octobe 2025, espectively.

Adjusted g oss ma gi is defi ed as the diffe e ce betwee the selli g p ice a d the cost of p oducts a d se vices (i cludi g employee be efits expe se).

Adjusted EBITDA is defi ed as ope ati g p ofit, excludi g (i) dep eciatio , amo tizatio a d impai me t losses o o -cu e t assets, et of eve sals; (ii) o – ecu i g i come a d expe ses, as p ese ted i the G oup’s co solidated i come stateme t u de “Othe i come” a d “Othe expe ses”; a d (iii) items that do ot eflect the G oup’s o di a y ope ati g pe fo ma ce (i pa ticula busi ess eo ga izatio a d adaptatio costs, costs elati g to acquisitio s a d exte al g owth t a sactio s, as well as IFRS 2 sha e-based payme t expe se).

Adjusted EBIT is defi ed as ope ati g p ofit, excludi g (i) o – ecu i g i come a d expe ses, as p ese ted i the G oup’s co solidated i come stateme t u de “Othe i come” a d “Othe expe ses”; a d (ii) items that do ot eflect the G oup’s o di a y ope ati g pe fo ma ce (i pa ticula busi ess eo ga izatio a d adaptatio costs, costs elati g to acquisitio s a d exte al g owth t a sactio s, as well as IFRS 2 sha e-based payme t expe se). Dep eciatio , amo tizatio a d eve sals of impai me t losses o o -cu e t assets i cluded i adjusted EBIT exclude the amo tizatio of the po tio of o -cu e t assets a isi g f om pu chase p ice allocatio .

Leve age atio is calculated as et debt / adjusted EBITDA, as defi ed i the G oup’s Se io C edit Facilities Ag eeme t, e te ed i to as pa t of the efi a ci g ca ied out i co ectio with the IPO.

Fo wa d-looki g stateme ts

Ce tai i fo matio i cluded i this p ess elease is ot histo ical fact but co stitutes fo wa d-looki g stateme ts. These fo wa d-looki g stateme ts a e based o cu e t beliefs, expectatio s a d assumptio s, i cludi g, without limitatio , assumptio s ega di g p ese t a d futu e busi ess st ategies a d the e vi o me t i which Exose s ope ates, a d i volve k ow a d u k ow isks, u ce tai ties a d othe facto s, which may cause actual esults, pe fo ma ce o achieveme ts to diffe mate ially f om those exp essed i o implied by the fo wa d-looki g stateme ts i cluded i this p ess elease. These isks a d u ce tai ties i clude those set out a d detailed i Chapte 4 “Risk facto s a d isk ma ageme t system” of the U ive sal Regist atio Docume t filed o 9 Ma ch 2026 with the F e ch fi a cial ma kets autho ity (Auto ité des ma chés fi a cie s – AMF) u de umbe D.26-0072. Fo wa d-looki g stateme ts speak o ly as of the date of this p ess elease, a d the G oup exp essly disclaims a y obligatio o u de taki g to elease a y updates o evisio s to a y fo wa d-looki g stateme ts i cluded i this p ess elease to eflect a y cha ge i expectatio s o a y cha ge i eve ts, co ditio s o ci cumsta ces o which these fo wa d-looki g stateme ts a e based. Fo wa d-looki g i fo matio a d stateme ts a e ot gua a tees of futu e pe fo ma ce a d a e subject to va ious isks a d u ce tai ties, ma y of which a e difficult to p edict a d ge e ally beyo d the co t ol of the G oup. Actual esults could diffe mate ially f om those exp essed i , o implied o p ojected by, fo wa d-looki g i fo matio a d stateme ts. This p ess elease is p ovided fo i fo matio pu poses o ly. It does ot co stitute, a d should ot be deemed to co stitute, a offe to the public of secu ities.

1 Like-fo -like.2 Net p ofit f om co ti ued ope atio s excludi g €(20.6) millio et o -cash impact of t adema k impai me t.3 The i te im co solidated fi a cial stateme ts fo the half-yea e ded 30 Ju e 2026 we e app oved by the Compa y’s Boa d of Di ecto s at its meeti g o 27 July 2026 a d have bee subject to a limited eview by the Compa y’s statuto y audito s.4 Followi g the divestme t of the G oup’s Mic owave Amplificatio busi ess, completed o 31 Decembe 2025, the 2025 half-yea figu es have bee estated i acco da ce with IFRS 5. Restated co solidated fi a cial stateme ts a e p ovided i the appe dices of this p ess elease.5 I cludi g €(28.2) millio o -cash impai me t cha ge a d +€7.6m defe ed tax liability ca cellatio i H1 2026.6 Net p ofit f om co ti ued ope atio s excludi g €(20.6) millio et o -cash impact of t adema k impai me t.

Attachme t

• Exose s_P ess Release_H1 2026_VA_FINAL